Mesoblast Limited
MEOBF
$1.55
-$0.04-2.52%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 265.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 265.63% | |||
| Cost of Revenue | 0.00% | 15.63% | |||
| Gross Profit | 0.00% | 92.53% | |||
| SG&A Expenses | 0.00% | 29.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | -851.70% | |||
| Total Operating Expenses | 0.00% | 40.99% | |||
| Operating Income | 0.00% | 33.30% | |||
| Income Before Tax | 0.00% | 26.57% | |||
| Income Tax Expenses | 0.00% | 277.12% | |||
| Earnings from Continuing Operations | 0.00% | 25.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 25.91% | |||
| EBIT | 0.00% | 33.30% | |||
| EBITDA | 0.00% | 36.17% | |||
| EPS Basic | 0.00% | 27.23% | |||
| Normalized Basic EPS | 0.00% | -7.48% | |||
| EPS Diluted | 0.00% | 26.76% | |||
| Normalized Diluted EPS | 0.00% | -7.48% | |||
| Average Basic Shares Outstanding | 0.00% | 1.47% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||